U.S. market Open. Closes in 5 hours 45 minutes

HRMY | Harmony Biosciences Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue582.02M437.86M305.44M159.74M6.00MN/A
Cost of Revenue121.24M83.48M55.52M27.74M1.58MN/A
Gross Profit460.79M354.37M249.92M132.00M4.42MN/A
Operating Expenses268.76M234.19M162.39M115.02M150.32M41.44M
Selling, General & Admin192.69M163.30M132.03M95.57M80.73M29.07M
Research & Development76.06M70.89M30.37M19.45M69.59M12.37M
Other Operating Expenses159.00K169.00K16.00K-3.07MN/AN/A
Operating Income192.03M120.19M68.70M3.68M-145.90M-41.44M
Other Expenses / Income-9.61M-15.50M-31.28M-40.62M-6.07M1.54M
Before Tax Income173.40M104.69M37.43M-36.94M-151.98M-39.90M
Income Tax Expenses44.54M-76.78M2.83M14.91M6.07M1.54M
Net Income128.85M181.47M34.60M-51.86M-158.05M-39.90M
Interest Expenses23.76M15.67M23.97M28.22M6.07MN/A
Basic Shares Outstanding59.47M59.17M57.53M56.89M63.68M49.24M
Diluted Shares Outstanding60.37M61.10M59.21M56.89M63.68M49.24M
EBITDA231.28M120.36M87.54M13.91M-142.69M-41.26M
EBITDA Margin39.74%27.49%28.66%8.71%-2,380.22%0.00%
EBIT197.15M120.36M61.40M-8.72M-145.90M-38.36M
EBIT Margin33.87%27.49%20.10%-5.46%-2,433.76%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙